Hernia Mesh Devices Global Market Report 2024

The hernia mesh devices market size has grown strongly in recent years. It will grow from $4.02 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historical period can be ascribed to factors such as clinical acceptance, an aging population, the development of hospital infrastructure, an increase in respiratory disorders, and the implementation of clinical studies and guidelines.

The hernia mesh devices market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be credited to factors such as the prevalence of chronic diseases, preparedness for global health crises, increased awareness and education, a shift towards non-invasive therapies, and the prominence of homecare settings. Noteworthy trends expected in the forecast period encompass the development of portable and lightweight high-flow nasal cannula (HFNC) devices, a focus on patient-centric design and comfort features, the introduction of wireless monitoring and connectivity, application in non-invasive ventilation (NIV) strategies, a focus on evidence-based clinical guidelines, and the integration of advanced flow control algorithms.

The hernia mesh devices market is anticipated to experience significant growth due to the rising prevalence of hernia repairs. Hernia repair is a surgical intervention aimed at strengthening the weakened abdominal wall and returning the hernia bulge to its proper position. Hernia mesh devices play a crucial role in these procedures, reducing the risk of recurrence and improving patient outcomes. A report from the National Library of Medicine in August 2023 highlighted that approximately 800,000 repairs are conducted annually for inguinal hernias in the United States alone, underscoring the increasing frequency of hernia repairs and its impact on the market.

The expansion of the hernia mesh devices market is also expected to be fueled by the growing population of individuals with obesity. Obesity, characterized by abnormal or excessive fat accumulation, poses health risks and necessitates effective solutions. Hernia mesh devices are frequently employed in obese populations to enhance support for weakened tissue and reduce recurrence rates compared to traditional suture repair. As of March 2022, the World Health Organization reported that over 1 billion people worldwide are currently obese, with 650 million being adults, 340 million adolescents, and 39 million children. The projection that around 167 million people will face health challenges related to overweight or obesity by 2025 further emphasizes the role of the growing obese population in propelling the hernia mesh devices market.

The market's growth during the forecast period may face challenges due to the high development costs of hernia repair devices. These devices, used in surgical procedures for treating hernias, encompass various mesh implants, sutures, and related products. The substantial expenses associated with research, development, and clinical testing often lead manufacturers to price their products higher to recoup these costs. Consequently, hospitals and healthcare facilities may bear the burden of more expensive hernia mesh devices. In 2021, Healthmonix reported that over 1 million hernias, mainly inguinal hernias, are treated annually in the United States, incurring an average cost of $2,000 to $2,500 per procedure. This results in an annual healthcare expenditure of approximately $2.5 billion. The elevated development costs of hernia repair devices are thus impeding the growth of the hernia mesh devices market.

Key players in the market are actively working on innovative devices to enhance patient outcomes and reduce complications. For instance, W. L. Gore & Associates Inc., a US-based materials science company, launched the GORE SYNECOR Intraperitoneal Biomaterial in February 2021. This hernia mesh device is designed for treating ventral or incisional hernias requiring non-absorbable bridging or strengthening material. Its unique composition, featuring a bioabsorbable foam layer and a microporous weave of thick monofilament, reflects the company's commitment to innovation and excellence.

In July 2021, BD Healthcare, a US-based medical technology company, acquired Tepha Inc., expanding its product portfolio in the soft tissue repair and regeneration market. Tepha Inc., a medical device company, specializes in manufacturing hernia mesh devices. This acquisition enables BD to utilize Tepha's technology for creating surgical meshes that facilitate the regeneration and repair of soft tissues, including hernia repair.

Major companies operating in the hernia mesh devices market report are Johnson & Johnson Services Inc., 3M Company, Medtronic PLC, Stryker Corporation, GE HealthCare Technologies Inc., Betatech Medical, Ethicon Inc., B. Braun Melsungen AG, W.L. Gore & Associates Inc., Cook Medical Inc., Samyang Corporation, Integra Life Sciences Pvt. Ltd., LifeCell Corporation, Meril Life Sciences Pvt Ltd., Sinolinks Medical Innovation Inc., Aspide Medical S.A.S., C.R. Bard Inc., Bard Inc., Deep Blue Medical Inc., Changzhou Medical Equipment General Factory Co. Ltd., Katsan Katgut Sanayi ve Tic. A.S., BioCer Entwicklungs-GmbH, Dipromed S.r.l., Herniamesh S.r.l., Novus Scientific AB, Gem S.r.l., Atrium Health, Primequal SA.

North America was the largest region in the hernia mesh devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hernia mesh devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hernia mesh devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A hernia mesh device is a medical implant or surgical mesh employed in the treatment of hernias. A hernia arises when an organ or fatty tissue protrudes through a weakened spot or opening in the surrounding muscle or connective tissue, typically occurring in the abdominal wall. Hernia mesh devices are utilized in hernia repair surgeries to provide support to damaged tissue and reinforce the abdominal wall, thereby reducing the risk of recurrence.

The primary categories of hernia mesh devices include biologic mesh and synthetic mesh. Biologic mesh, also referred to as bioprosthetic mesh or biological mesh, is a variety of surgical mesh utilized in hernia repair and other soft tissue surgeries. These meshes find application in various procedures, including open surgeries, laparoscopic surgeries, and robotic surgeries for incisional hernia, umbilical hernia, inguinal hernia, femoral hernia, and other types, performed by hospitals, clinics, ambulatory surgical centers, and other end users.

The hernia mesh devices market research report is one of a series of new reports that provides hernia mesh devices market statistics, including hernia mesh devices industry global market size, regional shares, competitors with a hernia mesh devices market share, detailed hernia mesh devices market segments, market trends and opportunities, and any further data you may need to thrive in the hernia mesh devices industry. This hernia mesh devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hernia mesh devices market consists of sales of synthetic mesh, composite mesh, absorbable mesh, mesh with coating, 3D meshes, and mesh kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.